@eramark46
Active 1 year, 3 months ago
No complications were attributable to pyeloperfusion. Three of 45 patients with biopsy-proven renal cell carcinoma experienced local recurrence resulting in local recurrence-free survival of 92% (95% confidence interval, 81.5%-100%) 3 years after ablation. Conclusions Retrograde pyeloperfusion of the renal collecting system is a relatively safe […] View